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Abstract: Hyphenated HPTLC has been used to analyze several neutral sphingolipids acting 
as lysosomal storage disease (LSD) biomarkers. Automated multiple development (AMD) 
provides separation of lipid peaks, which are detected and quantified using fluorescence 
detection by intensity changes (FDIC) after primuline post-impregnation. A final online 
transfer to a mass spectrometer by means of an elution-based interface allows their 
identification using electrospray ionization (ESI) and atmospheric pressure chemical 
ionization (APCI).Given that the increases in fluorescent emission detected by FDIC are 
produced by non-specific, electrostatic interactions between the primuline and hydrocarbon 
chains in the ceramide backbones of sphingolipids, it is a non-destructive detection technique, 
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allowing the precise location and transfer of biomarker peaks to a mass spectrometer using 
an elution interface. By using primuline as a fluorophore, the technique is also compatible 
with ESI-APCI and does not interfere with the MS of sphingolipids. APCI provides useful 
and complementary structural information to the ESI for sphingolipid identification. 
Moreover, FDIC emission can be used for quantitative purposes. Results include the 
determination of sphingomyelin (SM) in human-plasma samples (RSD < 6%) by means of 
a standard addition method with non-linear calibration, and the identification of 
globotriaosylceramide (Gb3) in the plasma of a Fabry patient. Only one HPTLC plate is 
needed to perform the analysis. 
Keywords: TLC-MS; induced fluorescence; automated multiple development; primuline; 
sphingolipids 
 
1. Introduction 
Lysosomal storage diseases (LSDs) are a group of approximately 50 rare, inherited metabolic 
disorders caused by lysosomal dysfunction, usually as a consequence of the deficiency of a single 
enzyme, which causes accumulation of different sphingolipids (SLs) within the cell [1]. Among these, 
certain neutral SLs, such as glucosylceramide (GluCer), globotriaosylceramide (Gb3), and 
sphingomyelin (SM), have been considered biomarkers of Gaucher, Fabry, and Niemann–Pick diseases, 
respectively. Increased concentrations in body fluids (plasma, urine) and certain tissues have been 
associated with progression of the disease or response to Enzyme Replacement Therapy [1–5]. 
A number of works suggest that several related isoforms and analogs of the aforementioned SLs [4], 
in addition to their lyso-derivatives [5,6], may also be potentially reliable biomarkers of certain diseases. 
SLs are not pure compounds. Each SL is a mixture of several isoforms (from different fatty acid derived 
chains coupled by amide linkage to the sphingoid chain in the ceramide) and analogs (from sphingoid-
bases other than d18:1 sphingosine). A lyso-SL has the same polar group as the related SL but only the 
sphingoid chain instead of the complete ceramide moiety. 
Recently, Schiffmann et al. [7] found that Gb3 is elevated not only in patients with Fabry disease but 
also in the general population of patients with non-Fabry-related heart disease. According to this study, 
elevated Gb3 may be a risk marker with prognostic value for assessment of near-term risk of death. 
Separation and identification of SL isoforms and analogs take advantage of the high resolutive power 
of gradient separation by Ultrahigh Performance Liquid Chromatography (UPLC/UHPLC) coupled with 
tandem mass spectrometry [5,6,8]. However, this technique is complex and costly, in equipment and 
maintenance, in run time per sample, and in data processing time. LC-based hyphenated systems are 
designed for obtaining all possible information about the sample in a single experiment [9]. Such systems 
require the development of expensive and complex equipment and the ability to handle large amounts 
of data. Once a run starts, it cannot be aborted, meaning that this mode of operation leads to high costs 
in time and solvents. This may not necessarily be the best option in the case of samples for which 
different information is sought. 
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HPTLC has been the technique of choice for lipids, and is particularly well adapted to providing 
lipid-class separations [10]. 
High Performance Thin-Layer Chromatography (HPTLC) has benefited from great instrumental 
development in recent years. HPTLC is now a fully automated and computerized analytical  
technique [11], which makes possible the design of original hyphenated instrumental methods that are 
well suited to a particular analytical issue [9]. As an example, fine-tuned separations can be achieved 
using AMD, an automated technique that combines incremental multiple development and solvent 
gradient elution [12]. Likewise, separations can be coupled to MS [9]. 
HPTLC may be a useful tool for lipidomics owing to its ease of use, reasonable speed of analysis, 
and the high number of samples processed per plate. 
HPTLC can be a complementary tool for LC-based techniques, particularly for routine clinical analyses. 
Different approaches [10,13] had previously been used for the HPTLC of neutral SLs. However, 
performing a full SL analysis on the same HPTLC plate posed several problems as samples required 
separation, detection, quantification, and, finally, transfer to an MS system for their characterization. 
Automated multiple development (AMD) was able to provide fine separation of SLs, but common, 
non-destructive, direct detection and quantification using UV scanning densitometry [12,14–24] was not 
possible owing to their poor UV absorption properties. Derivatization with CuSO4/H3PO4 [14–22], 
orcinol [25–28], or resorcinol [24] provided UV detection and quantification, but required heating or 
other severe conditions that would lead to sample destruction and prevent SL characterization. Non-
destructive, unspecific fluorescent revealing agents, such as primuline, had also been used for qualitative 
visualization of separated SLs, as they show an increase in fluorescence emission without any apparent 
chemical reaction [10,13,23,25–30], but a general lack of knowledge of the mechanisms  
behind the generation of the fluorescent signal hindered the possibility of using these procedures for 
quantitative analysis. 
More light has now been shed on the mechanism of fluorescence induction. Fluorophores such as 
primuline increase their emission in the presence of molecules bearing hydrocarbon chains [31,32] as a 
result of dipolar-induced, non-specific interactions between the fluorophore and analyte in a silica gel 
medium [33,34]. Cationic fluorophores, such as berberine or coralyne, show good examples of this 
behavior in the presence of saturated hydrocarbons [33,35] and also of SLs [12]. The longer the alkyl chain, 
the higher the fluorescent response. A model has been proposed to explain increases in emission [32,33]. 
The application of this effect to HPTLC-scanning densitometry is referred to as FDIC [12,34]. The 
magnitude of emission can be modulated through chromatographic parameters and fluorophore 
concentration, and FDIC can be used for quantitative purposes [36] through a simple plate post-
impregnation step. 
For use in the MS characterization of SLs, the elution head-based TLC-MS interface allows a simple, 
direct and modular connection of HPTLC with API-MS techniques [37–39]. A solvent is pumped 
through a head onto the plate to elute the whole substance zone, inclusive of its depth profile. The peak 
at that position is quickly extracted from the HPTLC plate; this has been reported to be satisfactory even 
for quantification down to the pg/band range [40]. As a related example, non-glycosylic SLs from 
Stratum Corneum were separated and transferred from a silica gel plate to MS using this interface [15]. 
However, derivatization of a second plate with CuSO4/H3PO4 was required in order to locate the 
corresponding bands. 
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Moreover, primuline has been reported to be compatible with electrospray ionization (ESI), which 
involves the use of an off-line, manual procedure [26–29]. Therefore, our approach in this work was to 
study the use of primuline as an FDIC post-impregnation fluorophore to locate and quantify SLs, as this 
also allows direct sample transfer using an elution head-based TLC-MS interface to Atmospheric 
Pressure Ionization (API)-MS equipment for further analysis. 
With regard to API sources, ESI has mostly been used in HPTLC for characterizing relatively high 
polar compounds [40], but it does not work well with less polar ones that are not correctly ionized. In 
this context, the use of APCI as a complementary tool to ESI showed potential for SL identification. 
The purpose of this paper is to establish the basis and evaluate the viability of one-plate HPTLC 
neutral SL analysis of human plasma samples using an original hyphenated method that provides AMD 
separation, FDIC detection and quantitative determination, and Atmospheric Pressure Ionization (API-
MS) identification of compounds, using APCI and ESI by means of an elution-based interface. 
The optimization of individual steps and their sequential combination for identifying and determining 
SLs is presented, including examples of SM determination in two plasma samples and the identification 
of Gb3 in a Fabry patient plasma. 
2. Experimental Section 
2.1. Fluorophore 
Primuline (dye content 50%; CAS number: 8064-60-6) was supplied by Sigma-Aldrich, Inc. (St. 
Louis, MO, USA). See Figure 1 (1; n = 0.1) for its chemical structure, and 3.4 for a detailed explanation. 
2.2. SL Standards and Plasma Samples 
Saturated hydrocarbons n-tetracosane (C24, >99%; [646-31-1]); n-octacosane (C28, ≥98%; [630-02-4]); 
n-dotriacontane (C32, ≥98%; [544-85-4]) were purchased from Fluka (Steinheim, Germany). 
SL standards were purchased from Matreya LLC (Pleasant Gap, PA, USA), unless otherwise stated. 
Their structures are shown in Figure 1: 2, GluCer (98%; MW = 784); 3, lactosyl ceramide (LacCer, 
98+%; [4682-48-8]; MW = 890); 4, Gb3, (98+%; [71965-57-6] CAS; MW = 1137); 5, SM (≥97%; 
[85187-10-6] CAS: MW = 731).These were applied on the plates individually. 
Plasma samples were obtained from the Aragon Institute of Health Sciences after approval of the 
Ethical Committee of Aragon, Spain. 
2.3. Sample Treatment 
Before their application in the hyphenated system, samples were treated according to a procedure 
described elsewhere [41]. For 250 µL aliquots, vials were extracted for 30 min with 2 mL of  
CHCl3–Methanol (MeOH) (1:1, v/v) in an overhead shaker, and centrifuged for 10 min at 5000 rpm. 
Precipitated protein was removed. The upper layer was submitted to alkaline hydrolysis by adding  
75 µL of 2 M NaOH, and incubated with magnetic stirring for 2 h at 40 °C. Subsequently, 1 mL of water 
and 1 mL of MeOH were added, and vials were centrifuged at 5000 rpm for 20 min. The lower layer 
containing the neutral SLs was then transferred to a new vial and dried under N2. Samples were 
reconstituted in 250 µL of CH2Cl2 (DCM)–MeOH (1:1, v/v). 
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Figure 1. Chemical structures of primuline (1), and studied sphingolipids: glucosylceramide 
(GluCer, 2); lactosylceramide (LacCer, 3); globotriaosylceramide (Gb3, 4); sphingomyelin 
(SM, 5). (See text for definition of n). 
2.4. Plates for HPTLC Separation 
Glass silica gel HPTLC plates, 10 × 20 cm; 3–10 µm particle size; 60 Å pore size; 0.2 mm thick layer 
from Merck (Darmstadt, Germany), were used. Plates were cleaned before use by elution with 
tetrahydrofuran (THF) in a conventional, vertical developing chamber up to the end of plate (100 mm), 
and air dried. 
2.5. AMD-FDIC-MS Hyphenated System: Description and Conditions for SL Analysis 
2.5.1. Sample Application 
Standards and samples were dissolved in a 1:1 v/v mixture of HPLC-grade DCM (99.5%) and MeOH 
(99.9%), from Scharlau (Barcelona, Spain). They were applied using the Automatic TLC Sampler 4 
(Camag, Müttenz, Switzerland), in 4 mm bands. Typically, up to 28 samples were applied on the same 
plate, starting at 10 mm with a distance of 2.5 mm between tracks. One track was always empty, as a 
blank run. The distance from lower edge of plate was 10 mm. 
For migration experiments, SL standards were used with typical application volumes of between  
0.1 and 3 µL, and concentration range from 0.01 µg μL−1 to 1 µg μL−1. Applied volumes of plasma were 
25 µL for Gb3 identification, and 0.6 µL for SM determination. 
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2.5.2. HPTLC Using AMD 
An AMD2 system (Camag, Müttenz, Switzerland) was used. The optimized operating conditions for 
separating the studied SLs were: MeOH–DCM gradient from 50:50 to 10:90 v/v, in seven steps over a 
total developing distance of 90 mm (Table 1). The run duration was 1 h 15 min. 
Table 1. AMD solvent gradient conditions for separating SM and Gb3 in human plasma samples. 
 MeOH (vol %) DCM (vol %) Migration (mm) 
Step 1 50 50 30 
Step 2 50 50 30 
Step 3 50 50 30 
Step 4 50 50 30 
Step 5 50 50 30 
Step 6 30 70 60 
Step 7 10 90 90 
The optimized operating conditions for separating SM from the rest of the whole plasma were: 
MeOH–DCM gradient from 80:20 to 50:50 v/v, in two steps over a total developing distance of 50 mm 
(Table 2) (hereafter “short” development). The run duration was 19 min. 
Table 2. AMD solvent gradient conditions for separating SM in human plasma samples. 
 MeOH (vol %) DCM (vol %) Migration (mm) 
Step 1 80 20 20 
Step 2 50 50 50 
2.5.3. FDIC Using Fluorescence Scanning Densitometry 
A TLC Scanner 3 (Camag, Müttenz, Switzerland) was used in UV (190 nm) and fluorescence modes, 
using primuline as fluorophore for FDIC (λexc = 365 or 406 nm; λem > 400 nm or >540 nm, respectively). 
In the case of fluorescence, post-impregnation was performed by dipping the plates into solutions of 
primuline in MeOH (200 mg L−1) using a Camag Chromatogram Immersion Device III. 
2.5.4. Coupling AMD-FDIC to API-MS 
A TLC-MS Interface (Camag, Müttenz, Switzerland) equipped with a 4 × 2-mm extraction head was 
used together with a PU-2080 HPLC pump (from Jasco, Tokyo, Japan). N2 pressure was 3 bars. A2-
μmstainless steel filter was used to remove the silica gel. Extraction was performed with MeOH at  
0.2 mL min−1. A blank portion of silica gel plate was also extracted as a control. 
An Esquire 3000 Plus ion trap mass spectrometer (Bruker Daltonics, Bremen, Germany) was used 
with ESI and APCI sources. Solvents were MeOH for APCI, and either MeOH or a mixture of 90:10 v/v 
MeOH and 0.1% v/v formic acid solution for ESI. Nebulizer (N2) gas pressure, drying (N2) gas flow 
rate, and drying gas temperature were set at 40 psi, 9.0 Lmin−1, and 350 °C, respectively. 
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ESI-MS ion-trap analysis was conducted in positive mode, with capillary and endplate offset voltages 
of 4000 and −500 V, respectively. Spectra were acquired in the m/z 300–1500 range at the 
Standard/Normal scan mode. 
APCI ionization conditions were as follows: capillary voltage 2000–3000 V; current intensity 
5000–6000 nA; nebulizer pressure 45 psi; flow and temperature of drying gas 5 mLmin−1 and 350 °C, 
respectively; vaporization temperature 450 °C. Full scans were recorded up to 1500 m/z in positive  
ion mode. 
Bruker Daltonics software packages Esquire Control v.5.3 and Data Analysis v.4.0 were used to 
control the MS apparatus and process data, respectively. 
2.6. Repeatability of Sample Treatment 
Three aliquots of plasma were submitted to sample treatment in three different vials. After treatment, 
samples were applied in triplicate on three different HPTLC plates. After using the short AMD 
development sequence, the SM peak was measured by FDIC (λexc = 365 nm; λem > 400 nm) under the 
conditions described in 2.5.3. A control run of 1 µg of SM standard was always applied on each plate to 
normalize the fluorescence signal. 
Analysis of variance (ANOVA) of results showed that there were no significant differences between 
FDIC responses (area counts) of the SM obtained under these conditions (RSD% = 4; F = 0.4241). 
2.7. Calibration and Quantification of SM in Plasma Using FDIC 
Calibration by the standard addition method was used for SM quantification in two human plasma 
samples. In each case, six plasma calibration solutions were prepared from six aliquots of 250 µL of the 
plasma sample and 100 µL of SM solutions in chloroform–methanol (CHCl3–MeOH; 1:1, v/v) with 
concentrations of 0.21, 0.42, 0.63, 0.84, 1.05, and 1.26 µg µL−1 (0.126, 0.251, 0.377, 0.502, 0.628, and 0.753 
µg of added SM on the applied sample). Both the plasma and standard solutions were submitted to the 
treatment procedure (see Section 2.3). 
A volume of 0.6 µL of treated human plasma and its six plasma calibration solutions were applied in 
triplicate on three HPTLC plates on different days (n = 9). 
A scheme of the application of plasma sample and calibration solutions on a silica gel HPTLC plate 
for SM determination is given as supplementary data. 
3. Results and Discussion 
3.1. Primuline as an FDIC Fluorophore 
The effect of hydrocarbon chains on primuline fluorescence emission intensity can be seen in Figure 2. 
Long-chain, non-fluorescent, saturated hydrocarbons (C24, C28, C32) provide strong increases in 
primuline emission without any change in emission wavelength. For the alkane homologous series, 
fluorescence response is a function of chain length, i.e., hydrocarbon polarizability, as demonstrated for other 
fluorophores [32–34]. This effect of chain length was also observed for neutral lipids and SLs using 
berberine as a fluorophore [12]. Therefore, primuline behaves as a FDIC fluorophore. 
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The presence of a sufficiently long hydrocarbon chain modifies the fluorophore microenvironment in 
silica gel, and hence the balance between radiative and non-radiative constants. A model based on weak, 
non-specific, induced dipole electrostatic interactions between the analyte and fluorophore has been 
proposed. For a given fluorophore and a homologous series of compounds, emission intensity depends 
on analyte polarizability (αi) [32,33]. The analyte provides an apolar environment that prevents non-
radiative de-excitation pathways. 
 
Figure 2. Effect of hydrocarbon chain: C24 ( ), C28 (○), C32 (Δ), and sample load on 
fluorescent detection by changes in primuline emission intensity. Conditions: samples load 
from 0.01 to 3 µg; application point at 10 mm; bands of 4mm; AMD in one step with  
n-heptane as mobile phase over 30 mm total migration distance; FDIC-primuline  
(200 mg L−1) at λexc = 365 nm; λem > 400 nm.  
The different fluorescent responses of compounds depend on the polar groups that are associated with 
the hydrocarbon chains in the molecule. Specific interactions of polar groups with a fluorophore increase 
the value of knr and either emission decreases (with regard to that of hydrocarbon chains) or even 
quenching may be observed if this contribution prevails [34]. For example, it has been reported that 
berberine experiences high emission increases in the presence of saturated hydrocarbons. However, it 
gives low increases in the presence of SLs [12]. As shown in Section 3.3, primuline provides different 
fluorescent responses for the studied SLs. 
3.2. AMD-Gradient Separation of SLs 
The use of AMD provides efficient, gradient-based sample separation. Separation takes place in 
several steps of increasing development length in which the mobile phase composition may be different. 
As each development step goes a little farther than the previous one, there is also a refocusing effect. 
Several development schemes for SLs have mostly been applied to Stratum Corneum, a skin-derived 
sample with a high concentration in ceramide-based lipids [14–22]. The number of steps depends on the 
nature of other neutral lipids coexisting in the sample with target SLs. 
A separation of SM, Gb3, LacCer, and GluCer, was reported in a previous work using an 18-step, 
universal gradient (MeOH–DCM, from 80:20 to 0:100, v/v) [12]. 
0
2000
4000
6000
8000
10000
0 1 2 3
F
lu
o
re
s
c
e
n
c
e
 r
e
s
p
o
n
s
e
 (
a
re
a
 a
.u
.)
mass (mg)
Chromatography 2015, 2   175 
 
Separation of neutral SLs on silica gel plates takes place according to lipid polarity. Glycosphingolipids 
were separated according to the number of sugar units: Gb3 (3 units), LacCer (2 units), and GluCer 
(1 unit), with increasing migration distances. By using the universal gradient scheme described, the more 
polar the compound, the lower the migration distance. Polar SM gives the lowest migration distance. 
The long duration of this sequence (4 h 15 m) was due to the large number of steps involved, long 
total migration distance (m.d., 76 mm, plus an additional cleaning stage of 90 mm in a vertical 
developing chamber), and the duplication of each elution step for increased peak refocusing. 
Regardless of the sequence used in an AMD separation, a final cleaning step is always needed in 
order to drag impurities traveling with the solvent front outside the zone of interest. Solvent additives, 
such as stabilizers and dry matter, and many other non-absorbing compounds, can be detected by FDIC. 
Impurities may come from compounds adsorbed during analysis, which are usually distributed uniformly 
on the plate. Impurities may also be the result of a matrix effect. This is important when working with 
lipid standards, and more particularly in the case of biological samples. 
Taking this method as a starting point, AMD separation was optimized. Refocusing seemed 
convenient as the SL standards were not pure compounds and their peaks may not have been narrow 
enough after a single elution step. However, when studying the behavior of each standard during a multi-
step elution, we noticed that refocusing was only needed in the case of Gb3. 
Use was made of a faster, seven-step MeOH–DCM gradient from 50:50 to 10:90, v/v, with 20% 
variation between steps, without losing separation quality and keeping a final cleaning step up to  
90 mm as a total m.d. Selected AMD conditions are described in Table 1. Separation of standards is 
shown in Figure 3A. Peak positions were determined by FDIC. 
 
Figure 3. HPTLC-FDIC chromatograms of: (A) standards, SM, 0.5 µg, m.d. 14.1 mm (a), 
Gb3, 1 µg, m.d. 29.6 mm (b), LacCer, 1 µg, m.d. 47.6 mm (c), and GluCer, 1 µg, m.d.  
55.9 mm (d). (B) plasma from a Fabry patient (25 µL). SM 16.8 mm (a), Gb3 27.4 mm (b). 
Application point at 10 mm; AMD conditions in Table 1. FDIC-primuline (200 mg L−1) at 
λexc = 406 nm; λem > 540 nm.  
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A final step (10:90) dragged impurities to 90 mm, on the apolar side of the chromatogram where there 
was no interference with the target peaks, improving the baseline. Separation of the four studied SL 
stook 1 h 15 min. 
The chromatogram showing the application of this AMD sequence to a plasma sample from a Fabry 
patient is shown in Figure 3B. As migration distance was not a sufficient criterion for attributing peak 
identity, identification of peaks at 16.8 and 27.4 mm by means of online MS is discussed in Section 3.5. 
Shorter sequences can be designed for a single target analyte. For example, SM can be separated from 
the entire human plasma sample matrix in 19 min using a 2-step MeOH–DCM gradient (30 mm step−1), 
from 80:20 to 50:50, v/v, over 50 mm of total developing distance (Table 2, Figure 4). Attribution of 
SM identity to the peak at 13.7 mm is detailed in 3.5. The large peak at m.d. of 50 mm includes all the 
remaining peaks of the plasma sample. 
 
Figure 4. HPTLC-FDIC chromatogram of plasma from a healthy volunteer (0.6 μL): SM, 
m.d.13.7 mm (a). Application point at 10 mm; AMD conditions in Table 2. FDIC-primuline 
(200 mg L−1) at λexc = 365 nm; λem > 400 nm. 
3.3. FDIC of Separated SLs Using Primuline 
The fluorescent chromatograms shown in Figures 3 and 4 were obtained by impregnation of plates 
with primuline after AMD separation and excitation under the conditions described in the Experimental 
section. Primuline provides sensitive fluorescent peaks with areas 5–7 times higher than those from UV 
detection at 190 nm (see supplementary data). In the case of SM and GluCer, the limits of detection 
(LOD) were 0.3 and 0.03 µg for UV and primuline induced-fluorescence, respectively. In the case of 
Gb3, they were 2 and 0.2 µg, respectively. LacCer showed the same LOD in UV and fluorescence: 0.3 µg. 
Figure 5 represents responses vs. sample load of SL standards using primuline-induced fluorescence. 
The FDIC emission signal of SLs was intense, despite their poor absorption properties and not being 
fluorescent molecules. As explained in Section 3.1, increases in the fluorescence emission of SLs are 
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due to their associated long hydrocarbon chains. For a given chemical family, the longer the chain length, 
the higher the fluorescent response. The different fluorescent responses of SLs depend on the balance 
between these increases in emission and the quenching produced by the polar head-groups that are 
associated with hydrocarbon chains in the SL structure. 
The use of FDIC for quantification of SLs is addressed in Section 3.6, where a calibration procedure 
based on standard addition was used to determine SM in plasma. 
 
Figure 5. Fluorescent responses (area counts) vs. sample load of SL standards: SM (0), Gb3 ( ), 
LactoCer (Δ), and GlucoCer (◊). FDIC-primuline (200 mg L−1) at λexc = 365 nm; λem > 400 nm. 
3.4. Online AMD-FDIC-MS Coupling 
Primuline can be used in combination with the TLC-MS elution interface and is compatible with  
API-MS, as shown in Figure 6, which illustrates a blank run of a primuline-impregnated silica gel plate 
under the conditions described in the Experimental section. This spectrum provides interesting structural 
information on primuline composition. Fragmentation is compatible with the description of primuline 
as not being a pure compound, but a mixture of oligomers of substituted benzothiazoles, according to Li 
et al. [42]. Structures attributed to MS-fragments are given in Figure 6, where n is the number of units 
of benzothiazole. Thus, the molecular ion (m/z = 453.9) corresponds to both 2'-(4-aminophenyl)-6-
methyl-[2,6'-bibenzo[d]thiazole]-7-sulfonic acid and2'-(4-aminophenyl)-6-methyl- 
[2,6'-bibenzo[d]thiazole]-5-sulfonic acid isomers, with n = 1. Likewise, the fragment at m/z = 321.0 
corresponds to the isomers with n = 0: 2-(4-aminophenyl)-6-methylbenzo[d]thiazole-7-sulfonic acid and 
2-(4-aminophenyl)-6-methylbenzo[d]thiazole-5-sulfonic acid. Despite Li et al. [42] also isolating traces 
of oligomers with n = 2 and n = 3 by silica gel column chromatography of primuline and subsequent 
purification using preparative reversed phase HPLC, we did not find these structures in MS spectra. 
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Figure 6. APCI-MS spectrum of primuline eluted from a portion of a primuline-impregnated 
silica gel plate using the TLC-MS interface (Conditions in the Experimental section). 
3.5. Identification of SLs Using AMD-FDIC-(API)-MS 
FDIC allows peak coordinates to be fixed. Thus, the TLC-MS elution interface extracts each separated 
HPTLC peak from the primuline-impregnated plate for an online transfer to API-MS. Primuline-
impregnated plates can be used in combination with MS for SL identification because their MW range 
(<454 uma) does not interfere with those of studied SLs. Furthermore, the intensity of signals for the SL 
spectra obtained from primuline-impregnated plates is similar to that obtained from pure silica gel plates 
under the selected APCI conditions. By working at 3000 V and 5000 nA, ionization of primuline does 
not compete with SL ionization, and the signal intensity from APCI mass spectra is adequate. 
ESI and APCI provide complementary information on a given SL for identification of peaks from 
standards and plasma samples directly recorded from the plate, using the interface. 
Figures 7–9 correspond to the mass spectra of the SM standard and SM separated from two different 
human plasma samples, respectively. Figures 10 and 11 correspond to the mass spectra of the Gb3 
standard and Gb3 separated from a plasma sample of a Fabry patient. 
 
Figure 7. Cont. 
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Figure 7. MS spectra of the peak corresponding to SM standard from a primuline-
impregnated plate, eluted using the TLC-MS interface (see Experimental section). (A) 
APCI-MS and (B) ESI-MS (PC: phosphocholine). 
 
 
Figure 8. Detail of an MS spectrum of the peak corresponding to SM from a plasma sample 
from a healthy volunteer, and eluted using the TLC-MS interface (see Table 2 and Figure 4). 
(A) APCI-MS and (B) ESI-MS. 
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Figure 9. Broad M/Z window of an ESI-MS spectrum of the peak corresponding to SM from 
a plasma sample and transferred using the TLC-MS interface (see Table 1 and Figure 3B). 
 
 
Figure 10. MS spectra of the peak corresponding to the Gb3 standard from a primuline-
impregnated plate, eluted using the TLC-MS interface (see the Experimental section). (A) 
APCI-MS and (B) ESI-MS. 
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Figure 11. MS spectrum of the peak corresponding to Gb3 from a plasma sample of a Fabry 
patient, and eluted using the TLC-MS interface (see Table 1 and Figure 3B). (A) APCI-MS 
and (B) ESI-MS. 
The peak at 27.4 mm in the plasma sample of a Fabry patient in Figure 3B was unequivocally 
identified as Gb3 (Figure 11). The ESI spectrum showed an [M+Na]+ ion of m/z = 1046.5, which 
corresponded to its d18:1/16:0 isoform. This was reported to be the most predominant form of Gb3 in 
plasma from Fabry patients [4]. 
In general, ESI provided [M+Na]+, and also [M+H]+ in some cases; APCI gave a more complex 
fragmentation pattern, with fragments corresponding to Cer moieties. For a given SL standard, isoforms 
between C16 and C24 were identified in MS. 
In the case of SM (Figures 7–9), [M+Na]+ and [M+H]+ were observed in ESI spectrum and 
[M+H−phosphocholine]+ fragments were observed in the APCI spectrum. In order to show fragmentation in 
detail, the figures depict the ranges of m/z corresponding to the different isoforms found. 
In a plasma sample (Figure 8), the peak at 13.1 mm (separated using the short AMD sequence; see 
Figure 4) can be attributed to SM. In fact, ESI and APCI-MS spectra directly obtained from this peak 
showed similar fragments to those of the SM standard (Figure 7). A fragment corresponding to  
[M−H2O−PC]+ was in APCI-MS of SM from plasma sample. Its probable origin is the random 
dehydration that occurred during the sample treatment procedure. Thus, in general, the isoforms found 
in the peak separated from the plasma were in agreement with those found in the SM standard. As 
expected, their relative distribution was different in the standards, of porcine origin, and in human  
plasma samples. 
In a plasma sample separated using the longer AMD sequence (see Figure 3B), the peak at 16.8 mm 
can also be attributed to SM for the same reason. Figure 9 shows the ESI spectrum corresponding to this 
peak, recorded in a broad MW range, which includes the zone m/z > 1000. This spectrum shows that 
globosides were not found in the SM peak from this sample. 
In the case of glycosphingolipids, [M+Na]+ were observed in ESI spectra, and fragments 
corresponding to [M+H−H2O−n hexoses]+ were observed in APCI spectra. The APCI spectrum 
corresponding to the Gb3 standard (Figure 10A) showed fragments corresponding to the sequential loss 
of one, two, and three glucose units to give the Cer backbone. A low relative abundance of [M+H−H2O]+ 
was also noticed. Similar fragmentation occurred in the case of LacCer and GluCer, whose spectra can 
be found in the supplementary data. 
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This ion was of low intensity, given that Gb3 is found in low concentrations in plasma, and this 
compound presented problems with ionization in ESI. In spite of low sensitivity, this was the first online 
detection of Gb3, from a HPTLC plate, from human plasma, as far as the authors are aware. 
On the other hand, Gb3 in our healthy plasma samples was under LOD of ESI-MS under the described 
conditions. According to the literature, Gb3 in plasma from Fabry patients, determined by a HPLC-MS 
technique, is found in higher concentrations than in healthy controls [4]. Consequently, in another work 
using a similar technique, Quehenberger et al. did not report Gb3 in healthy plasma samples [43]. 
3.6. Quantitative Analysis of SLs by FDIC 
The addition of a low percentage of the SL standard to the sample before treatment using the 
previously described method allows its use for the determination of human SLs using the standard 
addition method, owing to the fact that the migration distances of both standards and their counterpart 
human-peaks are the same and all ceramide-based hydrocarbon chains can be detected by FDIC. Two 
human plasma samples were submitted to the analytical procedure described in Section 2.7. 
Second-order calibration curves were obtained when plotting FDIC response (area counts) vs. added 
SM (µg). The concentration of the analyte (xextr) was calculated as the absolute value of the added SM 
corresponding to a null response, by extrapolation of the polynomial fitting (x-axis intercept). 
The results are given as: 
XSM = Xextr ± Sv (1) 
with XSM in ppm, and Sv being the standard deviation calculated according to the method described by 
Koscielniak [44] for polynomial standard addition fitting. 
Figure 12 shows the calibration curves of FDIC response vs. added SM (µg). The fluorescence signal 
from different plates was normalized using a control run of an SM standard (1 µg). Therefore, relative 
fluorescence was used instead of FDIC response (Area counts). 
 
(A) 
Figure 12. Cont. 
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(B) 
Figure 12. Calibration curve representing relative fluorescence vs. amount of added SM (µg) 
for SM determination in two human plasma samples by a non-linear standard addition 
method (see conditions in Section 2.7). 
Requirements for non-linear calibration by the standard addition method are accomplished [44] 
relative to the degree of curvature of parabolic function (Q > 0), number (n = 6) and size of additions, 
and number of measurements (n = 9). 
Results obtained were 280 ±17 (n = 9) mg L−1 for volunteer 1 and 289 ±12 (n = 9) mg L−1 for volunteer 
2. The uncertainty of the determination was lower than 6% (RSD). The results fall inside the ranges 
previously given in the literature for concentration of SM in plasma [45–47]. 
4. Conclusions 
We present the basis of an online, HPTLC-based hyphenated technique that allows the separation, 
identification, and quantification of certain SLs from the same plate. Our results suggest that this method 
can be used for SL determination in human-derived plasma. 
Separation by AMD, peak detection and quantification by FDIC using primuline, and a direct transfer 
of peaks from the primuline-impregnated plate to API-MS using an elution head based-interface are the 
sequential steps of the technique. Quantification of SM in plasma is performed by FDIC using calibration 
with a non-linear standard addition method. 
The use of HPTLC involves manual operations to transfer the plates from one module to another 
(AMD, densitometer, and interface). Far from being a disadvantage, this confers a high degree of 
flexibility. Information can be obtained for unknown bands of a large number of samples on the same 
plate (as many as 28,in this case), in a reasonable time, under strictly identical conditions, restricted to 
desired zones if required, with minimal solvent requirements, reduced time and effort, and important 
cost savings. 
SL identification is guaranteed by the use of SL standards during AMD, and by API-MS. In this 
regard, the results show that APCI can be a valuable tool for SL identification. 
Chromatography 2015, 2   184 
 
The understanding of induced-fluorescence mechanisms should enable other fluorophores to be 
proposed for improving detection sensitivity. 
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Supplementary materials can be accessed at: http://www.mdpi.com/2227-9075/2/2/167/s1. 
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